Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.
about
The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications.Betacellulin induces Slug-mediated down-regulation of E-cadherin and cell migration in ovarian cancer cells.AR-Signaling in Human Malignancies: Prostate Cancer and Beyond.Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system.
P2860
Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Flutamide and biomarkers in wo ...... linical and clinical evidence.
@ast
Flutamide and biomarkers in wo ...... linical and clinical evidence.
@en
Flutamide and biomarkers in wo ...... linical and clinical evidence.
@nl
type
label
Flutamide and biomarkers in wo ...... linical and clinical evidence.
@ast
Flutamide and biomarkers in wo ...... linical and clinical evidence.
@en
Flutamide and biomarkers in wo ...... linical and clinical evidence.
@nl
prefLabel
Flutamide and biomarkers in wo ...... linical and clinical evidence.
@ast
Flutamide and biomarkers in wo ...... linical and clinical evidence.
@en
Flutamide and biomarkers in wo ...... linical and clinical evidence.
@nl
P2093
P2860
P1476
Flutamide and biomarkers in wo ...... linical and clinical evidence.
@en
P2093
Angelika Gruessner
Christine Gruessner
Cynthia Laughren
Heather Wright
Jha'nae Stoffer
Katherine Glaser
Masoud Azodi
Nisreen AbuShahin
Samantha Pinkerton
Setsuko K Chambers
P2860
P304
P356
10.1158/1940-6207.CAPR-13-0408
P577
2014-06-20T00:00:00Z